Boston Scientific Executive and Leadership Team

Michael Gaisford, the Chief Executive Officer at Boston Scientific, directs the overarching corporate strategy and global business trajectory. Gaisford manages the integration of MedSurg and Cardiovascular segments to ensure consistent market leadership in minimally invasive medical devices. By aligning internal research initiatives with evolving healthcare demands, the Chief Executive Officer drives sustainable growth across international markets. Michael Gaisford maintains rigorous oversight of operational efficiency, ensuring that manufacturing processes meet the highest clinical standards. This leadership role involves constant collaboration with the Board to refine long-term investment priorities and expand the reach of life-saving technologies. Through strategic resource allocation, Gaisford strengthens the competitive position of the organization while fostering a culture of innovation. Ultimately, the Chief Executive Officer secures the financial health and clinical reputation of the company on a global scale.

Bernardo Del, the Director, Finance (Country & Chief Financial Officer (Mexico) at Boston Scientific, manages the fiscal health and financial planning for regional operations. Del directs budgeting, forecasting, and capital allocation to support the commercialization of medical devices within the Mexican market. Overseeing financial reporting and compliance, the Director, Finance (Country & Chief Financial Officer (Mexico) ensures that regional business activities align with global corporate standards. Bernardo Del collaborates with operational leaders to identify cost-saving opportunities and revenue growth drivers. This leadership role involves managing financial risk and ensuring the availability of resources for clinical distribution networks. By maintaining rigorous fiscal oversight, Del supports the expansion of minimally invasive technologies in the region. Ultimately, the Director, Finance (Country & Chief Financial Officer (Mexico) provides the financial stability required to deliver advanced healthcare solutions to providers and patients.

June Chang, the President (Greater China) at Boston Scientific, directs the commercial strategy and market expansion within the Greater China region. Chang oversees the distribution of minimally invasive technologies and manages relationships with key healthcare providers to ensure broad access to medical devices. By leading regional operations, the President (Greater China) adapts global product offerings to meet the specific clinical requirements of the local market. June Chang coordinates with internal teams to navigate regulatory landscapes and optimize supply chain logistics. This leadership role involves driving revenue growth through strategic partnerships and the introduction of advanced cardiac and interventional solutions. Through effective regional management, Chang strengthens the presence of the company in a high-growth market. Ultimately, the President (Greater China) ensures that the organization delivers high-quality medical outcomes to patients across the region.

Rafael Carbunaru, the Chief Technology Officer, Neuromodulation at Boston Scientific, architects the next generation of advanced neuro-interventional devices. Carbunaru directs the research and development pipeline for specialized cardiac and neurological hardware, ensuring that technical specifications align with clinical requirements. Overseeing the engineering teams, the Chief Technology Officer, Neuromodulation drives innovation in minimally invasive platforms to improve patient quality of life. Rafael Carbunaru collaborates with clinical researchers to translate complex medical data into scalable product designs. This leadership role involves managing the technical roadmap for the Neuromodulation segment, balancing rapid prototyping with rigorous safety testing. By optimizing device performance and reliability, Carbunaru maintains the technological edge of the company in a competitive global market. Ultimately, the Chief Technology Officer, Neuromodulation ensures that engineering breakthroughs directly support the clinical efficacy of the entire product portfolio.

Joseph Bockover, the Manager, Area Business & Strategy Chief of Staff at Boston Scientific, coordinates strategic planning and operational alignment across business units. Bockover directs the execution of high-priority initiatives that support the commercialization of minimally invasive technologies. Overseeing the synthesis of market data and internal performance metrics, the Manager, Area Business & Strategy Chief of Staff provides actionable insights to the executive leadership team. Joseph Bockover facilitates cross-departmental communication to ensure that business strategies remain consistent with the overarching corporate mission. This role involves managing complex projects that bridge the gap between clinical innovation and market delivery. By optimizing internal workflows and resource management, Bockover enhances the agility of the organization. Ultimately, the Manager, Area Business & Strategy Chief of Staff drives the operational discipline necessary to sustain long-term growth and clinical impact.

Ronald Morton, the Chief Medical Officer at Boston Scientific, directs the clinical strategy and medical safety protocols for the company's diverse device portfolio. Morton oversees the evaluation of clinical trial data to ensure that all products meet stringent efficacy and safety benchmarks. By providing medical guidance to product development teams, the Chief Medical Officer ensures that new technologies address critical gaps in patient care. Ronald Morton collaborates with healthcare providers to gather real-world evidence, which informs future product iterations and clinical applications. This leadership role involves managing the intersection of medical science and commercial strategy to drive the adoption of minimally invasive solutions. Through continuous monitoring of clinical outcomes, Morton maintains the reputation of the company as a leader in medical innovation. Ultimately, the Chief Medical Officer ensures that every technological advancement prioritizes patient safety and clinical excellence.

Kenneth Stein, the Senior Vice President and Global Chief Medical Officer at Boston Scientific, directs the global clinical research agenda and medical affairs strategy. Stein oversees the integration of clinical evidence into the development of advanced cardiac and interventional devices. By leading the global medical team, the Senior Vice President and Global Chief Medical Officer ensures that clinical standards remain consistent across all international markets. Kenneth Stein engages with regulatory bodies and medical societies to advocate for the adoption of minimally invasive technologies. This leadership role involves shaping the long-term clinical vision of the company to address complex patient needs. Through the oversight of large-scale clinical trials, Stein validates the performance of new medical solutions. Ultimately, the Senior Vice President and Global Chief Medical Officer drives the scientific credibility and clinical impact of the organization on a global scale.

Scott Kreiner, the Chief Medical Officer, Neuromodulation at Boston Scientific, directs the clinical development and medical strategy for the Neuromodulation business segment. Kreiner oversees the clinical validation of neuro-interventional devices, ensuring that all products meet the highest standards of patient safety and therapeutic efficacy. By providing medical expertise to the engineering and product teams, the Chief Medical Officer, Neuromodulation ensures that technological innovations address specific neurological conditions. Scott Kreiner collaborates with clinical investigators to design and execute studies that demonstrate the value of minimally invasive neuromodulation therapies. This leadership role involves managing the medical affairs function to support the commercialization of new devices. Through rigorous clinical oversight, Kreiner ensures that the company remains at the forefront of neurological care. Ultimately, the Chief Medical Officer, Neuromodulation drives the clinical success and therapeutic impact of the segment's product portfolio.

Chang Kim, the Head of Country at Boston Scientific, manages regional market penetration and local operational execution. Kim coordinates the commercialization of catheters, stents, and cardiac devices within specific geographic territories to optimize healthcare provider access. Overseeing local regulatory compliance and distribution networks, the Head of Country ensures that medical solutions reach clinical settings with maximum efficiency. Chang Kim directs cross-functional teams to adapt global product strategies to regional market nuances, thereby enhancing patient outcomes. This role requires constant engagement with local stakeholders to identify emerging clinical needs and drive adoption of minimally invasive technologies. By streamlining regional supply chains and fostering partnerships with healthcare systems, Kim supports the broader corporate mission of improving patient care. Ultimately, the Head of Country maintains the operational integrity and market growth of the organization within the assigned territory.

Brad Pulaski, the Regional Executive at Boston Scientific, directs the commercial performance and operational strategy within the assigned geographic territory. Pulaski oversees the implementation of sales and marketing initiatives for the company's suite of minimally invasive medical devices. By managing regional teams, the Regional Executive ensures that healthcare providers receive the necessary support and training to utilize advanced cardiac and interventional technologies effectively. Brad Pulaski collaborates with local stakeholders to identify market opportunities and address clinical challenges. This leadership role involves optimizing regional resource allocation to drive market share and improve patient outcomes. Through consistent monitoring of regional performance metrics, Pulaski maintains operational alignment with global corporate objectives. Ultimately, the Regional Executive secures the competitive position of the company by fostering strong relationships with clinical partners and delivering high-value medical solutions.